文献速递神经肿瘤

增殖增加与脑膜瘤中枢神经系统侵犯相关

Increased proliferation is associated with CNS invasion in meningiomas.
PubMed 文献 · J Neurooncol · 2021-11-20

该研究对1718例脑膜瘤进行Ki67增殖指数定量分析,其中108例(6.7%)组织学证实存在中枢神经系统侵犯。单因素和多因素分析显示,伴中枢神经系统侵犯的脑膜瘤Ki67增殖率显著更高(分别为P<0.0001和P=0.0098)。结论认为组织学中枢神经系统侵犯的脑膜瘤增殖活性更高。

要点

  • 1718例脑膜瘤中108例(6.7%)组织学证实存在中枢神经系统侵犯。
  • 伴中枢神经系统侵犯的脑膜瘤Ki67增殖率显著更高(单因素P<0.0001,多因素P=0.0098)。

核心结论

  • 组织学中枢神经系统侵犯的脑膜瘤表现出更高的增殖活性。

研究设计与样本

  • 对1718例脑膜瘤进行Ki67增殖标志物定量测量,并分析其与组织学确定的中枢神经系统侵犯及其他既定进展预后标志物的关联。
  • 常规Ki67免疫组化染色数字化后使用Image J软件进行自动定量。

主要发现

  • 共评估1718例脑膜瘤,其中108例(6.7%)见组织学中枢神经系统侵犯。
  • 单因素和多因素分析显示伴中枢神经系统侵犯的脑膜瘤Ki67增殖率显著更高(分别为P<0.0001和P=0.0098)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Meningiomas are the most common benign intracranial neoplasms. CNS invasion in meningiomas has been integrated into the 2016 WHO classification of CNS tumors as a stand-alone criterion for atypia. Since then, its prognostic impact has been debated based on contradictory results from retrospective analyses. The aim of the study was to elucidate whether histopathological evidence of CNS invasion is associated with increased proliferative potential. METHODS: We have conducted a quantified measurement of the proliferation marker Ki67 and analyzed its association with CNS invasion determined by histology together with other established prognostic markers of progression. Routine, immunohistochemical staining for Ki67 were digitalized and automatic quantification was done using Image J software. RESULTS: Overall, 1718 meningiomas were assessed. Histopathological CNS invasion was seen in 108 cases (6.7%). Uni- and multivariate analysis revealed a significantly higher Ki67 proliferation rate in meningiomas with CNS invasion (p < 0.0001 and p = 0.0098, respectively). CONCLUSIONS: Meningiomas with histopathological CNS invasion show a higher proliferative activity.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Behling F, Fodi C, Wang S, et al. Increased proliferation is associated with CNS invasion in meningiomas. J Neurooncol. 2021. PMID: 34800210. doi:10.1007/s11060-021-03892-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。